PATH vs UHS · P/E 19, rev $1.61B vs P/E 5.9, rev $15.83B
Uipath Inc (PATH) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported UHS revenue for 2024-12-31 was $15.83B. Net income was $1.16B. Revenue was up 10.8% from 2023-12-31 to 2024-12-31. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the PATH and UHS stock pages for the full models.
Not investment advice.